The manufacturers of a new drink that claims to treat Alzheimer's disease have been accused of promoting a dubious product that side steps regulations for complementary medicines.
Dr Ken Harvey, an Adjunct Associate Professor in the school of public health at La Trobe University, has complained to the Therapeutic Goods Administration about
Souvenaid, a new "medical food" which sells for about $4 a bottle.
He said the product, which is promoted by Nutricia Australia Pty Ltd as a "clinically proven" treatment of mild Alzheimer's disease, does not meet guidelines for such claims because the research behind it is "modest at best" and "of dubious clinical significance".
Continue reading
http://bit.ly/11Y3yaz
No comments:
Post a Comment